PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Lung Cancer|Ovarian Cancer|Uterine Cancer|Colorectal Cancer|Stomach Cancer|Esophageal Cancer|Pancreatic Cancer|Melanoma|Breast Cancer|Head and Neck Cancer|Soft Tissue Sarcoma|Rhabdomyosarcoma|Prostate Cancer
Interventions: DIAGNOSTIC_TEST: OmniSeq Test
Sponsor: Labcorp Corporation of America Holdings, Inc